361 related articles for article (PubMed ID: 32478016)
1. Clinical and Pathophysiological Insights Into Immunological Mediated Glomerular Diseases in Childhood.
Mastrangelo A; Serafinelli J; Giani M; Montini G
Front Pediatr; 2020; 8():205. PubMed ID: 32478016
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis and treatment of glomerulonephritis-an update.
Couser WG
J Bras Nefrol; 2016 Mar; 38(1):107-22. PubMed ID: 27049372
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of glomerular damage in glomerulonephritis.
Couser WG
Nephrol Dial Transplant; 1998; 13 Suppl 1():10-5. PubMed ID: 9507491
[TBL] [Abstract][Full Text] [Related]
4. Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies.
Servais A; Noël LH; Roumenina LT; Le Quintrec M; Ngo S; Dragon-Durey MA; Macher MA; Zuber J; Karras A; Provot F; Moulin B; Grünfeld JP; Niaudet P; Lesavre P; Frémeaux-Bacchi V
Kidney Int; 2012 Aug; 82(4):454-64. PubMed ID: 22456601
[TBL] [Abstract][Full Text] [Related]
5. [Clinical pathology of the glomerulus--from phenomenon to entity. The mesangial lesion].
Gärtner HV; Greschniok A; Wehrmann M; Bogenschütz O; Oliveira V; Mall A; Junghans R; Mikeler E; Bohle A
Verh Dtsch Ges Pathol; 1989; 73():41-60. PubMed ID: 2482629
[TBL] [Abstract][Full Text] [Related]
6. Membranoproliferative glomerulonephritis: no longer the same disease and may need very different treatment.
Noris M; Daina E; Remuzzi G
Nephrol Dial Transplant; 2023 Feb; 38(2):283-290. PubMed ID: 34596686
[TBL] [Abstract][Full Text] [Related]
7. Targeting leukocytes in immune glomerular diseases.
Kitching AR; Holdsworth SR; Hickey MJ
Curr Med Chem; 2008; 15(5):448-58. PubMed ID: 18289000
[TBL] [Abstract][Full Text] [Related]
8. Acute Post-Streptococcal Glomerulonephritis in Children: A Comprehensive Review.
Brant Pinheiro SV; de Freitas VB; de Castro GV; Rufino Madeiro BC; de Araújo SA; Silva Ribeiro TF; Simões E Silva AC
Curr Med Chem; 2022; 29(34):5543-5559. PubMed ID: 35702785
[TBL] [Abstract][Full Text] [Related]
9. Pathogenic mechanisms in membranoproliferative glomerulonephritis.
Smith KD; Alpers CE
Curr Opin Nephrol Hypertens; 2005 Jul; 14(4):396-403. PubMed ID: 15931011
[TBL] [Abstract][Full Text] [Related]
10. Glomerular Immune Deposition in MPO-ANCA Associated Glomerulonephritis Is Associated With Poor Renal Survival.
Lin W; Shen C; Zhong Y; Ooi JD; Eggenhuizen P; Zhou YO; Luo H; Huang J; Chen JB; Wu T; Meng T; Xiao Z; Ao X; Peng W; Tang R; Yin H; Xiao X; Zhou Q; Xiao P
Front Immunol; 2021; 12():625672. PubMed ID: 33841408
[TBL] [Abstract][Full Text] [Related]
11. Update on C3 Glomerulopathy: A Complement-Mediated Disease.
Caravaca-Fontán F; Lucientes L; Cavero T; Praga M
Nephron; 2020; 144(6):272-280. PubMed ID: 32369815
[TBL] [Abstract][Full Text] [Related]
12. Research advances on targeted-Treg therapies on immune-mediated kidney diseases.
Li Y; Liu H; Yan H; Xiong J
Autoimmun Rev; 2023 Feb; 22(2):103257. PubMed ID: 36563769
[TBL] [Abstract][Full Text] [Related]
13. Bright's disease today: the pathogenesis and treatment of glomerulonephritis--I.
Cameron JS
Br Med J; 1972 Oct; 4(5832):87-90 contd. PubMed ID: 4562073
[TBL] [Abstract][Full Text] [Related]
14. C3 glomerulonephritis and CFHR5 nephropathy.
Gale DP; Maxwell PH
Nephrol Dial Transplant; 2013 Feb; 28(2):282-8. PubMed ID: 23125424
[TBL] [Abstract][Full Text] [Related]
15. The role of the complement system in primary membranous nephropathy: A narrative review in the era of new therapeutic targets.
So BYF; Chan GCW; Yap DYH; Chan TM
Front Immunol; 2022; 13():1009864. PubMed ID: 36353636
[TBL] [Abstract][Full Text] [Related]
16. Complement dysregulation in glomerulonephritis.
Kaartinen K; Safa A; Kotha S; Ratti G; Meri S
Semin Immunol; 2019 Oct; 45():101331. PubMed ID: 31711769
[TBL] [Abstract][Full Text] [Related]
17. The role of the alternative pathway of complement activation in glomerular diseases.
Łukawska E; Polcyn-Adamczak M; Niemir ZI
Clin Exp Med; 2018 Aug; 18(3):297-318. PubMed ID: 29450785
[TBL] [Abstract][Full Text] [Related]
18. Proliferative glomerulonephritis with monoclonal IgG deposits: a distinct entity mimicking immune-complex glomerulonephritis.
Nasr SH; Markowitz GS; Stokes MB; Seshan SV; Valderrama E; Appel GB; Aucouturier P; D'Agati VD
Kidney Int; 2004 Jan; 65(1):85-96. PubMed ID: 14675039
[TBL] [Abstract][Full Text] [Related]
19. [Glomerulonephritis and vasculitis as causes of arterial hypertension].
Eicken S; Gugger M; Marti HP
Ther Umsch; 2012 May; 69(5):283-94. PubMed ID: 22547360
[TBL] [Abstract][Full Text] [Related]
20. Infection and glomerulonephritis.
Naicker S; Fabian J; Naidoo S; Wadee S; Paget G; Goetsch S
Semin Immunopathol; 2007 Nov; 29(4):397-414. PubMed ID: 17846774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
